Tag: $Amgen

Amgen starts two critical late-stage trials for weight loss drug MariTide

Amgen on Wednesday said it has started two critical late-stage trials for its experimental weight loss injection MariTide, another step in its bid to enter the booming obesity drug market. 

Amgen stock falls as analysts mull over weight loss drug’s bone density data

Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide.